CinCor Pharma Inc (CINC)
34.23
+2.23 (+6.97%)
USD |
NASDAQ |
Aug 11, 16:00
34.23
0.00 (0.00%)
After-Hours: 19:53
CinCor Pharma Income Statement
June 2022 - December 2020
Last Period
Last
Next Period
Prev Period
First Period
First
Income (Quarterly)
Other Income Metrics (Quarterly)
Future Periods
|
2022-06 | 2022-03 | 2021-12 | 2021-09 | 2021-06 | 2021-03 | 2020-12 | ||
Actual Release Date | 08/08/2022 | 05/10/2022 | -- | 01/07/2022 | 08/08/2022 | 05/10/2022 | -- | ||
Normalized Income | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | |
Total Expenses | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | |
EBIT | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | |
EBITDA | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | |
EBITDA Margin (Quarterly) | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
EPS Metrics (Quarterly)
Dividends (Quarterly)
Future Periods
|
2022-06 | 2022-03 | 2021-12 | 2021-09 | 2021-06 | 2021-03 | 2020-12 | ||
Actual Release Date | 08/08/2022 | 05/10/2022 | -- | 01/07/2022 | 08/08/2022 | 05/10/2022 | -- | ||
Dividend Per Share | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | |
Preferred Stock Dividend | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
Shares (Quarterly)
Future Periods
|
2022-06 | 2022-03 | 2021-12 | 2021-09 | 2021-06 | 2021-03 | 2020-12 | ||
Actual Release Date | 08/08/2022 | 05/10/2022 | -- | 01/07/2022 | 08/08/2022 | 05/10/2022 | -- | ||
Average Basic Shares Outstanding | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | |
Average Diluted Shares Outstanding | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |